Join Now

Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs

Collaboration strengthens Ratio’s long-term isotope supply strategy for clinical development and future pipeline growth.

Posted in BioUtah News | Tagged | Comments Off on Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs